摘要
目的 探讨卵巢上皮性肿瘤中叶酸受体（FR）α的表达及其临床病理学意义.方法 制备包括86例卵巢癌及29例卵巢交界性肿瘤的组织芯片,采用免疫组织化学EnVision法检测上述肿瘤组织中FRα的表达情况,同时采用即时PCR检测40例新鲜冷冻卵巢癌组织以及14例卵巢交界性肿瘤组织中FRα mRNA的表达情况.分析卵巢上皮性肿瘤中FRα表达水平与肿瘤的组织类型、不同发病模式以及临床分期的关系.结果 免疫组织化学染色结果显示,86例卵巢癌中有40例（46.5%）对FRα呈明确阳性反应,其中浆液性癌阳性表达率最高,为62.7%（32/51）,高于其他组织类型的癌（P=0.000）.按照卵巢癌发病模式区分,Ⅱ型卵巢癌FRα的表达明显高于Ⅰ型卵巢癌,差异具有统计学意义（P=0.001）.卵巢癌组FRα表达阳性率高于交界性肿瘤（46.5%∶27.6%）,但差异无统计学意义（P=0.074）.卵巢癌组FRα的表达与临床分期无相关性（P=0.498）.相似的结果也见于采用即时PCR检测FRα mRNA的表达情况：卵巢癌组FRα mRNA表达值高于交界性肿瘤组（P=0.000）,在交界性肿瘤中,浆液型mRNA表达值高于黏液型,差异具有统计学意义（P=0.007）.结论 卵巢上皮性肿瘤中FRα呈高表达,特别是在恶性肿瘤和浆液性肿瘤中.
Objective To investigate the expression of folate receptor（FR） α in ovarian epithelial tumors and its clinopathological significance. Methods Tissue microarrays （TMAs） were constructed from 86 epithelial ovarian cancers and 29 borderline ovarian tumors, followed by the FRα expression evaluation by immunohistochemistry. FRα mRNA expression was investigated by quantitative real-time PCR using freshfrozen tissues from 40 cases of ovarian carcinoma and 14 cases of borderline tumor. FRα expression levels in ovarian tumors were also analyzed in correlation with tumor morphology, pathogenesis and FIGO stage.Results FRα expression was detected in 40 of 86 （46.5%） of ovarian cancers, with the highest rate of expression observed in serous carcinomas （62.7%, 32/51） compared with that of the other cancer types （P=0.000）. Depending on pathogenesis type, FRα expressions in type Ⅱ ovarian carcinomas were significantly higher than those in type Ⅰ ovarian carcinomas （P = 0.001）. Ovarian carcinomas had a tendency to express higher FRα than the borderline tumors （46.5% vs 27.6%）, although statistically not significant （P = 0.074）. FRα expressions in ovarian carcinomas showed no correlation with the FIGO stage （P =0.498）. However, real-time PCR showed that FRα mRNA levels were significantly higher in ovarian carcinomas compared with that of the borderline tumors （P = 0.000） and also higher in serous ovarian borderline tumors compared with mucinous type （P = 0.007）. Conclusion Higher level of FRα expression occurs frequently in ovarian epithelial tumors, especially in carcinomas and ovarian serous tumors.
出处
《中华病理学杂志》
CAS
CSCD
北大核心
2010年第11期747-751,共5页
Chinese Journal of Pathology
基金
国家自然科学基金（30672224）
北京大学人民医院研究与发展基金（RDB2007-01）
关键词
卵巢肿瘤
组织阵列分析
叶酸受体
Ovarian neoplasms
Tissue array analysis
Folate receptor
